
Caribou Biosciences Inc (CRBU) Becoming More Attractive for Investors
Caribou Biosciences Inc’s recently made public that its President and CEO Haurwitz Rachel E. acquired Company’s shares for reported $20400.0
Caribou Biosciences Inc’s recently made public that its President and CEO Haurwitz Rachel E. acquired Company’s shares for reported $20400.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Caribou Biosciences
Caribou Biosciences Inc’s recent filing unveils that its President and CEO Haurwitz Rachel E. acquired Company’s shares for reported $20400.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Caribou Biosciences Inc’s recently made public that its Chief Legal Officer MCCLUNG BARBARA G unloaded Company’s shares for reported $4811.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Caribou Biosciences
Caribou Biosciences Inc’s recent filing unveils that its Chief Legal Officer MCCLUNG BARBARA G unloaded Company’s shares for reported $4811.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Caribou Biosciences
Caribou Biosciences Inc’s recent filing unveils that its Chief Legal Officer MCCLUNG BARBARA G unloaded Company’s shares for reported $4811.0
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.